Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Atala

Showing results (211-220 of 981) with videos related to

Pageof 99
Sort By:
Stem Cells Translational Medicine|February 8, 2017
Advancing the Translation of Stem Cells to MedicineAnthony Atala
The Journal of Urology|March 14, 2019
Re: Epigenetic Silencing of the Dual-Role Signal Mediator, ANGPTL4 in Tumor Tissues and Its Overexpression in the Urothelial Carcinoma MicroenvironmentAnthony Atala
Clinics in Plastic Surgery|November 19, 2003
Tissue engineering, stem cells, and cloning for the regeneration of urologic organsAnthony Atala
The Journal of Urology|January 15, 2013
Re: overexpression of androgen receptor enhances the binding of the receptor to the chromatin in prostate cancerAnthony Atala
The Journal of Urology|January 15, 2013
Re: Nkx3.1 and myc crossregulate shared target genes in mouse and human prostate tumorigenesisAnthony Atala
The Journal of Urology|February 12, 2013
Re: tumor radiation response enhancement by acoustical stimulation of the vasculatureAnthony Atala
The Journal of Urology|February 12, 2013
Re: synapse-directed delivery of immunomodulators using T-cell-conjugated nanoparticlesAnthony Atala
Stem Cells Translational Medicine|December 1, 2012
A new era in stem cells translational medicineAnthony Atala
The Journal of Urology|May 14, 2013
Re: Inhibition of Ca2+ -activated Cl- channel ANO1/TMEM16A expression suppresses tumor growth and invasiveness in human prostate carcinomaAnthony Atala
The Journal of Urology|April 9, 2013
Re: effectiveness of a combination therapy using calcineurin inhibitor and mTOR inhibitor in preventing allograft rejection and post-transplantation renal cancer progressionAnthony Atala
Pageof 99

Showing results (211-220 of 981) with videos related to

Sort By:
Pageof 99
Stem Cells Translational Medicine|February 8, 2017
Advancing the Translation of Stem Cells to MedicineAnthony Atala
The Journal of Urology|March 14, 2019
Re: Epigenetic Silencing of the Dual-Role Signal Mediator, ANGPTL4 in Tumor Tissues and Its Overexpression in the Urothelial Carcinoma MicroenvironmentAnthony Atala
Clinics in Plastic Surgery|November 19, 2003
Tissue engineering, stem cells, and cloning for the regeneration of urologic organsAnthony Atala
The Journal of Urology|January 15, 2013
Re: overexpression of androgen receptor enhances the binding of the receptor to the chromatin in prostate cancerAnthony Atala
The Journal of Urology|January 15, 2013
Re: Nkx3.1 and myc crossregulate shared target genes in mouse and human prostate tumorigenesisAnthony Atala
The Journal of Urology|February 12, 2013
Re: tumor radiation response enhancement by acoustical stimulation of the vasculatureAnthony Atala
The Journal of Urology|February 12, 2013
Re: synapse-directed delivery of immunomodulators using T-cell-conjugated nanoparticlesAnthony Atala
Stem Cells Translational Medicine|December 1, 2012
A new era in stem cells translational medicineAnthony Atala
The Journal of Urology|May 14, 2013
Re: Inhibition of Ca2+ -activated Cl- channel ANO1/TMEM16A expression suppresses tumor growth and invasiveness in human prostate carcinomaAnthony Atala
The Journal of Urology|April 9, 2013
Re: effectiveness of a combination therapy using calcineurin inhibitor and mTOR inhibitor in preventing allograft rejection and post-transplantation renal cancer progressionAnthony Atala
Pageof 99